Sumitomo Dainippon Pharma Co Ltd - Total Cashflows From Financing Activities

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Total-Cashflows-From-Financing-Activities" stands at -123.37 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 06/30/2023.

Sumitomo Dainippon Pharma Co Ltd's second quarter result of -47.19 Billion JPY for the item "Total Cashflows From Financing Activities" represents a decrease of -1,565.92 percent compared to it's first quarter result.

Also, Sumitomo Dainippon Pharma Co Ltd's second quarter result of -47.19 Billion JPY for the item "Total Cashflows From Financing Activities" represents a decrease of -24,477.08 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's second quarter result of -123.37 Billion JPY for the item "Total Cashflows From Financing Activities" represents a decrease of -61.53 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -126.99 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -126.99 Billion Japanese Yens.
The 3 year change is -88.54 Billion Japanese Yens.
The 5 year change is -355.83 Billion Japanese Yens.

The Serie's long term average value is -7.64 Billion Japanese Yens. It's latest available value, on 09/30/2025, is -115.73 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is +23.45 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 12/31/2019, to it's latest available value, on 09/30/2025, is -362.81 Billion.